Helix BioMedix Completes $2 Million Private Placement to Advance Xeroderma Pigmentosum Development Program
Financing strengthens balance sheet and accelerates advancement of proprietary DNA repair technology targeting UV-induced DNA damage. - August 29, 2026
Helix BioMedix Promotes Robin L. Carmichael to Chief Executive Officer
R. Stephen Beatty is appointed to Chief Investor Officer and Executive Chairman of the Board. - July 10, 2017
Press Releases 1 - 2 of 2